Global Endoscopic Ultrasound Market Size, Share, Trends & Growth Analysis Report Segmented By Product (Endoscope, Ultrasound Probe, Needle, Accessories, Ultrasonic Processors), Application, End Use And Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), 2026-2034

Endoscopic Ultrasound Market Size Overview

The Endoscopic Ultrasound Market size was valued at USD 2.27 Billion in 2025 and is projected to grow from USD 2.44 Billion in 2026 to USD 4.30 Billion by 2034, at a CAGR of 7.36% during the 2026-2034.

The endoscopic ultrasound (EUS) market is a rapidly evolving segment within the broader gastrointestinal and minimally invasive diagnostic industry. EUS is a cutting-edge technology that combines endoscopy and ultrasound to provide high-resolution images of the digestive tract and surrounding tissues. This dual modality allows for precise diagnostic and therapeutic interventions, including fine-needle aspiration, staging of gastrointestinal cancers, and assessment of pancreatic disorders.

The growing global prevalence of gastrointestinal diseases, such as pancreatic cancer, esophageal cancer, and chronic pancreatitis, is a key driver of market growth. According to the World Health Organization, gastrointestinal cancers are among the top five most commonly diagnosed cancers worldwide, underscoring the urgent need for advanced diagnostic tools like EUS. Furthermore, the minimally invasive nature of EUS has made it a preferred option for both patients and healthcare providers, reducing recovery times and improving diagnostic accuracy. Technological advancements, such as the integration of artificial intelligence in image analysis and the development of portable EUS devices, are further expanding its clinical applications. For instance, recent innovations have enabled real-time elastography, enhancing the ability to differentiate between benign and malignant tissues.

Market Dynamics
Endoscopic Ultrasound Market Drivers

• Rising Burden of Gastrointestinal Diseases: The increasing prevalence of gastrointestinal diseases is a significant driver for the endoscopic ultrasound market. According to the National Institute of Diabetes and Digestive and Kidney Diseases, approximately 60 to 70 million people in the United States are affected by digestive diseases annually, necessitating advanced diagnostic solutions like EUS. This growing disease burden has prompted healthcare providers to adopt innovative imaging techniques for early detection and treatment, thereby fueling market demand. Additionally, the rise in pancreatic and esophageal cancer cases globally has further emphasized the need for EUS as a critical diagnostic tool.
• Advancements in Minimally Invasive Techniques: The shift toward minimally invasive procedures is bolstering the adoption of EUS devices. Endoscopic ultrasound enables both diagnosis and therapeutic interventions with minimal patient discomfort and faster recovery times compared to traditional methods. The U.S. Food and Drug Administration highlights the rising approval rates of advanced minimally invasive devices, including EUS systems, to meet this demand. These advancements are particularly beneficial in managing chronic conditions, such as pancreatic cysts, as they allow precise interventions with reduced complication risks, driving market growth.
• Supportive Government Initiatives and Funding: Government bodies globally are increasing investments in cancer research and minimally invasive technologies, directly impacting the EUS market. For instance, the National Cancer Institute in the United States allocated over $6 billion in 2022 for cancer-related research, with a significant focus on improving diagnostic methods. Similar initiatives in Europe and Asia are aimed at enhancing healthcare infrastructure, enabling the integration of EUS systems into standard diagnostic protocols, thus fostering market expansion.
• Growing Aging Population: The aging population is contributing significantly to the rising demand for endoscopic ultrasound technologies. According to the United Nations, the global population aged 65 years and above is projected to reach 1.5 billion by 2050, increasing the incidence of age-related gastrointestinal disorders. Elderly patients are particularly susceptible to conditions such as pancreatic cancer and chronic liver diseases, making advanced diagnostic tools like EUS indispensable in providing effective care. This demographic trend is expected to substantially influence market dynamics over the coming years.
• Increasing Adoption of EUS in Oncology: The expanding role of endoscopic ultrasound in oncology is a pivotal driver for market growth. EUS-guided fine-needle aspiration (EUS-FNA) is increasingly utilized for precise cancer staging, especially for pancreatic and esophageal cancers. According to the American Cancer Society, over 64,000 new cases of pancreatic cancer were diagnosed in the United States in 2023, emphasizing the growing need for accurate diagnostic methods. The ability of EUS to assess tumor invasiveness and facilitate targeted biopsies has made it a cornerstone in cancer diagnostics, accelerating its adoption across oncology practices globally.
• Rising Healthcare Expenditures in Emerging Markets: The growing healthcare investments in emerging economies are significantly driving the adoption of endoscopic ultrasound technologies. According to the World Bank, healthcare spending in low- and middle-income countries has been increasing at an annual growth rate of 4.3%, enabling the procurement of advanced diagnostic devices like EUS. Countries in Asia-Pacific and Latin America are particularly focusing on improving healthcare accessibility and modernizing diagnostic capabilities. These developments are expanding the market footprint of EUS, as healthcare systems prioritize early diagnosis and minimally invasive interventions.

Endoscopic Ultrasound Market Opportunities

• Expansion of EUS Applications in Chronic Disease Management: There is a growing opportunity to expand the use of EUS in managing chronic conditions like liver fibrosis, gallbladder disease, and inflammatory bowel disease. According to the Centers for Disease Control and Prevention, chronic liver disease affects nearly 4.5 million adults in the United States annually, highlighting the need for precise diagnostic tools. The ability of EUS to provide high-resolution imaging and targeted biopsies positions it as an essential solution in long-term disease monitoring and intervention, creating significant market potential for advanced EUS technologies.
• Technological Integration with AI and Machine Learning: The integration of artificial intelligence and machine learning into EUS devices presents a transformative opportunity for enhanced diagnostic accuracy. AI algorithms can assist in real-time interpretation of ultrasound images, reducing diagnostic errors and improving efficiency. The National Institute of Health reports that AI-driven diagnostic tools have shown significant promise in early trials, especially for detecting early-stage cancers. This technological advancement is expected to drive innovation and adoption, providing a competitive edge to manufacturers in the EUS market.
• Untapped Potential in Rural Healthcare Settings: Expanding access to EUS in rural and underserved areas represents a critical growth opportunity. The World Health Organization highlights that nearly half of the global population lacks access to essential healthcare services, including advanced diagnostics. Portable and cost-effective EUS devices can bridge this gap, particularly in low-resource settings. By improving accessibility, healthcare providers can address unmet diagnostic needs, creating a new market segment for EUS technologies in remote regions.
• Rising Focus on Preventive Healthcare: The growing emphasis on preventive healthcare is driving demand for advanced diagnostic solutions like EUS. Preventive screening programs for gastrointestinal cancers, supported by initiatives from organizations such as the World Health Organization, are increasing globally. For instance, colorectal cancer screening campaigns have significantly increased diagnostic rates in at-risk populations. Incorporating EUS in these preventive protocols can enable earlier detection of precancerous lesions, thereby reducing treatment costs and mortality rates, while simultaneously expanding market opportunities.
• Emerging Markets in Asia-Pacific and Latin America: Asia-Pacific and Latin America are witnessing rapid healthcare infrastructure development, creating significant opportunities for the EUS market. According to the World Bank, healthcare spending in Asia-Pacific is expected to grow by 5% annually, driven by government initiatives to improve diagnostic capabilities. Countries such as India and Brazil are investing heavily in advanced medical equipment to meet rising healthcare demands. This regional growth trend is expected to provide manufacturers with new avenues for market expansion.

Endoscopic Ultrasound Market Restrain & Challenges

• High Cost of EUS Equipment: The elevated cost of endoscopic ultrasound devices and related procedures remains a significant barrier to adoption. Advanced EUS systems can cost upwards of $100,000, making them inaccessible to many smaller healthcare facilities, particularly in developing regions. According to the World Bank, nearly 85% of healthcare spending in low-income countries is out-of-pocket, limiting access to such expensive diagnostic technologies. This financial constraint hampers the widespread adoption of EUS and creates challenges for market penetration in cost-sensitive regions.
• Shortage of Skilled Professionals: The effective use of EUS devices requires specialized training, and the shortage of skilled professionals is a notable challenge. The American Society for Gastrointestinal Endoscopy notes that the demand for endoscopists trained in advanced imaging techniques exceeds the current supply, especially in rural and underserved areas. This skill gap limits the utilization of EUS technologies and reduces the overall efficiency of healthcare systems, particularly in regions where expertise is already limited.
• Limited Reimbursement Policies: Restrictive or inadequate reimbursement frameworks for EUS procedures pose challenges for market growth. According to the Centers for Medicare & Medicaid Services, many advanced diagnostic procedures, including EUS, are only partially reimbursed, leading to higher out-of-pocket costs for patients. This limitation discourages both healthcare providers and patients from opting for EUS, particularly in markets where insurance coverage is minimal or non-existent, thereby constraining its adoption.
• Technological Barriers in Developing Regions: lack of advanced healthcare infrastructure in developing regions hinders the adoption of EUS devices. The World Health Organization reports that many low- and middle-income countries face challenges in acquiring and maintaining high-tech medical equipment due to infrastructure deficits and inconsistent electricity supply. These barriers limit the deployment of EUS systems in resource-constrained settings, reducing market growth potential in these regions.
• Regulatory and Approval Challenges: Stringent regulatory requirements for the approval of new EUS devices can delay market entry for manufacturers. The U.S. Food and Drug Administration and similar agencies in Europe and Asia have rigorous processes to ensure device safety and efficacy. While necessary, these prolonged timelines can deter innovation and increase costs for companies trying to launch advanced EUS systems. This challenge is particularly significant for smaller manufacturers with limited resources to navigate complex regulatory landscapes.

Current Trends in the Endoscopic Ultrasound Market

• Integration of AI for Enhanced Diagnostics: Artificial intelligence is increasingly being integrated into endoscopic ultrasound systems to improve diagnostic precision and workflow efficiency. AI algorithms enable real-time analysis of ultrasound images, aiding in the differentiation of benign and malignant tissues. According to the National Institutes of Health, AI-powered EUS systems have demonstrated up to 90% accuracy in identifying early-stage pancreatic cancer in clinical trials. This trend is driving advancements in personalized medicine by enabling more precise disease diagnosis and treatment planning, thus gaining significant traction among healthcare providers.
• Development of Portable and Compact EUS Devices: The demand for portable endoscopic ultrasound systems is rising, driven by the need for flexible diagnostic solutions in outpatient and rural settings. Compact EUS devices are designed for ease of transport and operation, allowing healthcare providers to extend advanced diagnostic capabilities to underserved regions. The World Health Organization emphasizes the importance of portable medical devices in improving healthcare access for low-resource settings. This trend aligns with global initiatives to enhance the reach of advanced diagnostics, particularly in developing economies.
• Advancements in Elastography Integration: Elastography, which measures tissue stiffness, is increasingly being incorporated into EUS systems to improve diagnostic capabilities. The U.S. Food and Drug Administration highlights elastography as a key advancement for assessing liver fibrosis, pancreatic masses, and lymph node involvement. This non-invasive technique enhances the utility of EUS by providing additional diagnostic information, aiding in the early detection of malignancies. The rising adoption of EUS elastography reflects its growing role in the precise evaluation of gastrointestinal and hepatobiliary conditions.
• Expansion of Therapeutic EUS Applications: The use of EUS for therapeutic interventions, such as cyst drainage, tumor ablation, and neurolysis, is gaining momentum. The American Gastroenterological Association notes a significant increase in the adoption of EUS-guided therapeutic procedures, driven by their minimally invasive nature and improved patient outcomes. For instance, EUS-guided fine-needle injection of therapeutic agents is becoming a preferred option for treating pancreatic cysts, reducing the need for invasive surgery. This trend is reshaping the market by expanding the scope of EUS beyond diagnostics.
• Adoption of High-Definition Imaging Technology: High-definition imaging is revolutionizing the quality of visual outputs in EUS systems, enabling enhanced visualization of gastrointestinal structures and lesions. Modern EUS devices equipped with HD imaging provide greater clarity and detail, improving diagnostic accuracy for complex conditions. According to the Centers for Disease Control and Prevention, advancements in imaging technology contribute to more precise cancer staging and early detection of precancerous conditions. The increasing incorporation of HD imaging capabilities is driving innovation and elevating the clinical value of EUS technologies.

Contact Us

Segmentation Insights
Endoscopic Ultrasound Market Analysis, By Product

By Product, the market is divided into endoscope, ultrasound probe, needle, accessories, and ultrasonic processors.

• Endoscopes represent the largest segment in the global endoscopic ultrasound market due to their central role in diagnostic and therapeutic procedures. Their significance lies in providing high-resolution imaging of gastrointestinal and surrounding tissues, making them indispensable in detecting and managing conditions like pancreatic and esophageal cancers. According to the American Cancer Society, approximately 20% of gastrointestinal cancers are diagnosed using advanced endoscopic techniques annually, underscoring the critical importance of this product. The continuous advancement in endoscope technology, such as high-definition imaging and enhanced maneuverability, further strengthens its dominance in the market. This segment’s leadership reflects its foundational importance in enabling precision in EUS-guided interventions and its widespread adoption in healthcare facilities globally.
• The needle segment is experiencing the fastest growth due to the rising adoption of EUS-guided fine-needle aspiration (EUS-FNA) and fine-needle biopsy (EUS-FNB) for precise tissue sampling. This growth is driven by increasing demand for minimally invasive diagnostic methods, especially for staging cancers and detecting pancreatic lesions. The National Institutes of Health highlights that EUS-FNA achieves over 90% sensitivity in diagnosing pancreatic cancer, making it a gold-standard procedure in oncology. Furthermore, the development of advanced needles designed for higher accuracy and reduced patient discomfort is propelling the segment’s rapid expansion. The growing prevalence of gastrointestinal cancers and the emphasis on early diagnosis amplify the significance of this segment in modern medical practices.

Endoscopic Ultrasound Market Analysis, By Application

By Application Type, the market is categorized into gastrointestinal cancer, lung cancer, pancreaticobiliary disease, and others.

• Gastrointestinal cancer holds the largest share in the global endoscopic ultrasound market due to the high prevalence and diagnostic importance of EUS in this category. The World Health Organization reports that gastrointestinal cancers, including colorectal and esophageal cancer, account for nearly 4 million new cases globally each year. EUS plays a pivotal role in accurate cancer staging, guiding biopsies, and evaluating tumor progression, making it an essential tool in oncology. The ability of EUS to provide detailed imaging of gastrointestinal tissues and adjacent structures ensures its critical role in diagnosing these cancers. With increasing awareness and early screening initiatives worldwide, the use of EUS for gastrointestinal cancer diagnosis and management is expected to remain dominant in the market.
• The pancreaticobiliary disease segment is growing at the fastest rate, driven by the rising incidence of pancreatic disorders and biliary obstructions. According to the National Cancer Institute, pancreatic cancer is one of the most aggressive cancers, with over 64,000 new cases diagnosed annually in the United States alone. EUS has emerged as a gold standard for diagnosing pancreatic cysts, tumors, and bile duct abnormalities due to its minimally invasive nature and high diagnostic accuracy. Advances in therapeutic EUS applications, such as drainage of pancreatic fluid collections and bile duct stenting, are further fueling this segment’s rapid growth. The increasing demand for early diagnosis and effective treatment of pancreaticobiliary diseases is accelerating the adoption of EUS in this critical application area.

Endoscopic Ultrasound Market Analysis, By End Use

By End Use Type, the market is categorized into hospitals, ambulatory surgical centers, and others.

• Hospitals dominate the endoscopic ultrasound market due to their advanced infrastructure, availability of skilled professionals, and high patient footfall for complex diagnostic and therapeutic procedures. According to the American Hospital Association, U.S. hospitals conducted over 16 million endoscopic procedures in 2022, underscoring their role as primary centers for EUS applications. Hospitals are preferred for EUS-guided interventions, such as fine-needle aspirations and tumor staging, due to the need for multidisciplinary care. Additionally, government investments in healthcare facilities globally strengthen their capacity to adopt advanced diagnostic technologies, maintaining their leadership in this segment.
• Ambulatory surgical centers are the fastest-growing segment due to their cost-effectiveness, shorter patient wait times, and increasing focus on outpatient care. The Centers for Medicare & Medicaid Services notes that ASCs perform nearly 40% of outpatient surgical procedures in the United States, reflecting their growing importance. EUS adoption in ASCs is driven by the rising demand for minimally invasive procedures and improved patient convenience. Additionally, technological advancements in portable EUS systems enable their seamless integration into ASC workflows, making them an attractive option for providers and patients alike.

Endoscopic Ultrasound Market Regional Insights

The market has been geographically analysed across five regions, Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.

• North America holds the largest share of the global endoscopic ultrasound market, driven by advanced healthcare infrastructure, high healthcare expenditure, and widespread adoption of innovative diagnostic technologies. According to the Centers for Medicare & Medicaid Services, the United States spends over $4.3 trillion annually on healthcare, with a significant portion allocated to advanced diagnostic procedures. The region’s high prevalence of gastrointestinal and pancreatic cancers further boosts demand for EUS. The American Cancer Society reports that in 2023, over 152,000 cases of colorectal cancer were diagnosed in the U.S., many of which relied on EUS for staging and monitoring. Moreover, the presence of key market players such as Boston Scientific and Olympus Corporation in the region enhances accessibility to cutting-edge EUS technologies.
• Asia-Pacific is the fastest-growing region in the endoscopic ultrasound market due to rising healthcare investments, improving healthcare infrastructure, and a growing patient base. The World Bank reports that healthcare spending in Asia-Pacific has grown consistently by over 5% annually, particularly in countries like China and India. The region faces a high burden of gastrointestinal diseases, with the World Health Organization highlighting that gastric cancer is among the top causes of cancer-related deaths in East Asia. Governments are actively investing in diagnostic technologies to address these health challenges, with Japan and South Korea leading in adopting advanced EUS systems. The increasing demand for affordable, minimally invasive diagnostic options, coupled with a growing awareness of early disease detection, is expected to drive significant growth in the region.

Endoscopic Ultrasound Market Competitive Overview

The endoscopic ultrasound (EUS) market is characterized by intense competition among leading global players focusing on technological innovation, strategic collaborations, and regional expansions. Key players include Boston Scientific Corporation, Olympus Corporation, Fujifilm Holdings Corporation, and Pentax Medical. These companies are heavily investing in R&D to enhance product offerings, such as high-definition imaging capabilities and AI-assisted diagnostic systems. Strategic collaborations and acquisitions are further shaping the competitive landscape. The presence of local players in developing regions also intensifies competition, with smaller companies offering cost-effective solutions to address regional healthcare needs. This competitive dynamic underscores the market’s rapid evolution, driven by innovation, strategic partnerships, and an increasing focus on addressing unmet diagnostic and therapeutic needs worldwide.

Leading Market Players in the Endoscopic Ultrasound Market

• Boston Scientific Corp.: Boston Scientific is a global leader in the endoscopic ultrasound market, known for its innovative diagnostic and therapeutic solutions. The company’s EUS portfolio includes advanced systems like the EXALT Model D Single-Use Duodenoscope and AXIOS Stent and Electrocautery Enhanced Delivery System, which streamline pancreaticobiliary procedures. According to Boston Scientific, its products are used in over 120 countries, contributing significantly to the global adoption of minimally invasive techniques. Strategic acquisitions, such as the purchase of EMcision, have bolstered the company’s capabilities in therapeutic EUS applications. Additionally, Boston Scientific invests heavily in R&D, allocating approximately $1.2 billion annually, enabling the development of next-generation diagnostic technologies.
• Olympus Corporation: Olympus Corporation is a pioneer in imaging technologies and a leading player in the EUS market. Its cutting-edge EUS devices, such as the EU-ME2 ultrasound processor, are renowned for their high-resolution imaging and real-time elastography capabilities. Olympus is particularly strong in Asia-Pacific, leveraging its extensive distribution network and strong brand reputation. The company’s focus on innovation is evident in its consistent launch of advanced products, supported by a robust R&D expenditure of approximately $1 billion annually. According to Olympus, its endoscopy systems are used in over 70% of hospitals globally, highlighting its dominant presence in the medical imaging industry.
• FUJIFILM Medical Systems: FUJIFILM is a key player in the endoscopic ultrasound market, specializing in high-performance imaging systems. The company’s flagship products, such as the Fujifilm EG-580UT EUS scope, offer enhanced maneuverability and exceptional image clarity, making them popular among healthcare providers. FUJIFILM’s emphasis on innovation is supported by its significant investment in AI-powered diagnostic technologies, which aim to improve the accuracy of EUS-guided interventions. In India, FUJIFILM collaborates with healthcare providers to expand access to advanced diagnostic solutions, addressing the growing prevalence of gastrointestinal diseases. The company’s strong commitment to research and regional partnerships ensures its continued growth in the competitive EUS market.

Top Strategies Followed by Players

• Product Innovation and R&D Investments: Leading companies in the endoscopic ultrasound market prioritize innovation by investing heavily in research and development. For instance, Medtronic allocates over $2.5 billion annually to R&D, driving the development of advanced diagnostic tools with enhanced imaging capabilities. This focus on product innovation has led to breakthroughs like AI-assisted EUS systems, which improve diagnostic precision and workflow efficiency. These investments also enable players to cater to emerging clinical needs, such as minimally invasive cancer detection, strengthening their competitive edge and market presence globally.
• Strategic Partnerships and Collaborations: Collaborations with healthcare providers, academic institutions, and technology firms are a key strategy among market players. For instance, Cook Medical partners with hospitals to provide training programs for EUS-guided interventions, enhancing the adoption of its devices. Similarly, Olympus Corporation collaborates with research institutions to develop AI-powered imaging solutions, ensuring technological leadership. These partnerships allow companies to expand their reach, improve healthcare outcomes, and address specific regional needs, particularly in developing economies.
• Geographic Expansion into Emerging Markets: To tap into the high-growth potential of emerging regions, companies are expanding their operations in markets like Asia-Pacific and Latin America. Fujifilm India Pvt. Ltd., for instance, has focused on expanding its footprint in India by partnering with local distributors and healthcare providers. According to the World Bank, rising healthcare spending in these regions presents significant opportunities for market growth. By offering cost-effective solutions and establishing localized production facilities, companies are catering to unmet diagnostic needs and gaining a competitive advantage in these markets.

List of Companies Profiled in the Report are:

• Boston Scientific Corp.
• Medtronic
• ConMed
• Olympus Corp.
• Steris
• SonoScape
• Medical Corp.
• Pentex Medical
• Fujifilm India Pvt. Ltd.
• Cook Medical

Global Endoscopic Ultrasound Market Report Scope and Key Segmentation

List of Segments Covered

This section of the endoscopic ultrasound market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Endoscope
• Ultrasound Probe
• Needle
• Accessories
• Ultrasonic Processors

By Application

• Gastrointestinal Cancer
• Lung Cancer
• Pancreaticobiliary Disease
• Others

By End Use

• Hospitals
• Ambulatory Surgical Centers
• Others